Literature DB >> 20147958

Determinants of erectile dysfunction in type 2 diabetes.

F Giugliano1, M Maiorino, G Bellastella, M Gicchino, D Giugliano, K Esposito.   

Abstract

This study was designed to evaluate the prevalence and correlates of ED in a population of diabetic men. Consecutive patients with type 2 diabetes were recruited among outpatients regularly attending Diabetes Clinics. Inclusion criteria for the initial selection of patients were a diagnosis of type 2 diabetes for at least 6 months but less than 10 years, age 35-70 years, body mass index (BMI) of 24 or higher, HbA1c of 6.5% or higher: a total of 555 (90.8%) of the 611 men were analyzed in this study. ED was assessed by the IIEF-5 instrument. Approximately, 6 in 10 men in our sample of diabetic men had varying degrees of erectile dysfunction: mild 9%, mild to moderate 11.2%, moderate 16.9% and severe 22.9%. The prevalence of severe ED increased with age. Higher hemoglobin A1c (HbA1c) levels were associated with ED; similarly, the presence of metabolic syndrome, hypertension, atherogenic dyslipidemia (low levels of HDL-cholesterol and high levels of triglycerides) and depression was associated with ED. Physical activity was protective of ED; men with higher levels of physical activity were 10% less likely to have ED as compared with those with the lowest level. In conclusion, among subjects with type 2 diabetes glycemic control and other metabolic covariates were associated with ED risk, whereas higher level of physical activity was protective. These results encourage the implementation of current medical guidelines that place intensive lifestyle changes as the first step of the management of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147958     DOI: 10.1038/ijir.2010.1

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  32 in total

1.  Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction.

Authors:  Maarten Albersen; Guiting Lin; Thomas M Fandel; Haiyang Zhang; Xuefeng Qiu; Ching-Shwun Lin; Tom F Lue
Journal:  Urology       Date:  2011-05-31       Impact factor: 2.649

2.  Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo Study.

Authors:  S Furukawa; T Sakai; T Niiya; H Miyaoka; T Miyake; S Yamamoto; K Maruyama; T Ueda; H Senba; M Torisu; H Minami; M Onji; T Tanigawa; B Matsuura; Y Hiasa; Y Miyake
Journal:  Int J Impot Res       Date:  2016-11-17       Impact factor: 2.896

3.  Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Michela Petrizzo; Elisabetta Della Volpe; Rosanna Orlando; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2014-11-20       Impact factor: 3.633

4.  INFLUENCE OF THE DURATION OF DIABETES AND VIBRATION PERCEPTION THRESHOLD ON THE SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.

Authors:  P Singh; S Arora; A Goyal; N Mittal; A Singh; S Sharma; D M Shanthaiah; I K Dardi
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

5.  Prevalence and Severity of Erectile Dysfunction as Assessed by IIEF-5 in North Indian Type 2 Diabetic Males and Its Correlation with Variables.

Authors:  Arvind Goyal; Parminder Singh; Ashish Ahuja
Journal:  J Clin Diagn Res       Date:  2013-12-15

6.  Erectile dysfunction in young men with type 1 diabetes.

Authors:  M I Maiorino; G Bellastella; E Della Volpe; O Casciano; L Scappaticcio; P Cirillo; D Giugliano; K Esposito
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

7.  Independent Predictors of Erectile Dysfunction in Type 2 Diabetes Mellitus: Is It True What They Say about Risk Factors?

Authors:  Faranak Sharifi; Mohammad Asghari; Yahya Jaberi; Oveis Salehi; Fatemeh Mirzamohammadi
Journal:  ISRN Endocrinol       Date:  2012-08-27

8.  Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model.

Authors:  Bin Ouyang; Xiangzhou Sun; Dayu Han; Shenfu Chen; Bing Yao; Yong Gao; Jun Bian; Yanping Huang; Yadong Zhang; Zi Wan; Bin Yang; Haipeng Xiao; Zhou Songyang; Guihua Liu; Yuanyuan Zhang; Chunhua Deng
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

Review 9.  Diabetes and sexual dysfunction: current perspectives.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito
Journal:  Diabetes Metab Syndr Obes       Date:  2014-03-06       Impact factor: 3.168

10.  Prevalence of Sexual Concerns and Sexual Dysfunction among Sexually Active and Inactive Men and Women with Screen-Detected Type 2 Diabetes.

Authors:  Mette Bjerggaard; Morten Charles; Ellids Kristensen; Torsten Lauritzen; Annelli Sandbæk; Annamaria Giraldi
Journal:  Sex Med       Date:  2015-10-28       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.